4//SEC Filing
Puttagunta Sailaja 4
Accession 0001209191-23-057258
CIK 0001659323other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:00 PM ET
Size
9.6 KB
Accession
0001209191-23-057258
Insider Transaction Report
Form 4
Puttagunta Sailaja
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2023-12-01$2.12/sh−2,933$6,218→ 10,369 total - Award
Ordinary Shares
2023-12-01+8,333→ 13,302 total - Exercise/Conversion
Restricted Share Units
2023-12-01−8,333→ 16,666 total→ Ordinary Shares (8,333 underlying)
Footnotes (5)
- [F1]On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
- [F2]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F3]Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs.
- [F4]The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split.
- [F5]On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022, with a further 25% having vested on December 1, 2023.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001792314
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:00 PM ET
- Size
- 9.6 KB